Technical Analysis for RAPT - RAPT Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 24.6 -6.11% -1.60
RAPT closed down 6.11 percent on Friday, December 6, 2019, on 73 percent of normal volume.

Trend Table & Recent Signals

ADX Long-Term Intermediate-Term Short-Term
Very Strong N/A N/A Down
See historical RAPT trend table...

Date Alert Name Type % Chg
New Uptrend Bullish 0.00%
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion -6.11%
Shooting Star Candlestick Bearish -10.64%
Lizard Bearish Bearish Day Trade Setup -10.64%
Pocket Pivot Bullish Swing Setup -10.64%
Multiple of Ten Bearish Other -10.64%
Wide Bands Range Expansion -10.64%
Gapped Up Strength -10.64%
Upper Bollinger Band Touch Strength -10.64%

Older signals for RAPT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

RAPT Therapeutics, Inc., a clinical stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. The company develops small molecules that are designed to modulate the critical immune responses underlying these diseases. Its lead oncology drug candidate is FLX475 for the treatment of a range of tumors; and RPT193, a CCR4 antagonist for allergic inflammatory disease. The company is also pursuing a range of targets, including general control nonderepressible and hematopoietic progenitor kinase for the treatment of cancer. RAPT Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California. RAPT Therapeutics, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.
Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Industry Diseases Treatment Of Cancer Pharmacy Tumors Specialty Drugs Inflammatory Diseases Bristol Myers Squibb Small Molecule Therapies

Is RAPT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 42.0
52 Week Low 11.85
Average Volume 102,483
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 23.15
10-Day Moving Average 25.48
Average True Range 4.55
ADX 55.74
+DI 40.05
-DI 14.92
Chandelier Exit (Long, 3 ATRs ) 28.35
Chandelier Exit (Short, 3 ATRs ) 27.81
Upper Bollinger Band 30.22
Lower Bollinger Band 16.09
Percent B (%b) 0.6
BandWidth 61.03
MACD Line 2.90
MACD Signal Line 2.39
MACD Histogram 0.5079
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.97
Resistance 3 (R3) 30.42 29.08 29.08
Resistance 2 (R2) 29.08 27.71 28.86 28.78
Resistance 1 (R1) 26.84 26.87 26.17 26.39 28.48
Pivot Point 25.50 25.50 25.17 25.28 25.50
Support 1 (S1) 23.26 24.13 22.59 22.81 20.72
Support 2 (S2) 21.92 23.29 21.70 20.42
Support 3 (S3) 19.68 21.92 20.13
Support 4 (S4) 19.23